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A B S T R A C T
Spectroscopic photoacoustic imaging has the potential to become a powerful tool that can estimate
distributions of optically absorbing chromophores in the body. We have developed an algorithm to select
imaging wavelengths for spectroscopic photoacoustics given the spectra of expected chromophores. The
algorithm uses the smallest singular value of a matrix constructed from the absorption spectra as a
criterion to remove extraneous wavelengths. The method performed signiﬁcantly better than an
approach where evenly spaced wavelengths were used in the presence of noise and wavelength-
dependent attenuation of light in tissue. Finally, the algorithm was applied to photoacoustic imaging of a
phantom containing indocyanine green dye and silica-coated gold nanorods, demonstrating signiﬁcant
improvements in the ability to estimate relative contrast agent concentrations compared to the case
where evenly spaced wavelengths were chosen. In summary, our work provides a versatile framework to
select optical wavelengths and evaluate sets of absorbers for spectroscopic photoacoustic imaging.
 2013 The Authors. Published by Elsevier GmbH. 
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Photoacoustic (PA) imaging, also known as optoacoustic
imaging, is a rapidly growing biomedical imaging modality [1–
5]. PA imaging offers high contrast derived from differences in
optical absorption with excellent resolution at clinically relevant
depths. Endogenous chromophores, such as hemoglobin, melanin,
and lipids, can all be detected using PA imaging [6–8]. This shows
great promise for the noninvasive clinical detection and charac-
terization of atherosclerotic plaques [9,10] and certain tumors
[11]. Highly absorbing contrast agents (e.g., dyes or plasmonic
nanoparticles) are commonly used in conjunction with PA imaging
[12–16]. These contrast agents are often molecularly targeted to
observe a speciﬁc cellular expression or interaction, allowing for
further characterization of the disease [15,17].
The optical absorption spectra of the tissue components and
contrast agents vary greatly with optical wavelength. Therefore,* Corresponding author at: Department of Biomedical Engineering, The
University of Texas at Austin, 107 W. Dean Keeton, stop C0800, Austin, TX
78712, United States.
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Open access under CC BY-Nspectroscopic methods can be used to unmix the signals from
different optical absorbers in a photoacoustic image and provide an
estimate of their concentrations [8,13,18]. This technique is known
as spectroscopic PA (sPA) imaging. sPA imaging allows for accurate
measurement of blood oxygenation saturation (SO2) or nanoparti-
cle deposition in tissue [19,20].
A number of methods have been proposed to spectrally unmix
absorbers in PA images. One simple spectroscopic method uses a
ratio of the PA signals acquired at two optical wavelengths. This
ratio is then used to estimate either SO2 or the state of an
activatable contrast agent [21,22]. The main drawback of using a
ratio is that at most two absorbers can be distinguished, limiting
the potential applications. Intraclass correlation (ICC) has been
used to simultaneously identify multiple absorbers. ICC correlates
the measured PA spectrum at each pixel to the known absorption
spectra of the anticipated absorbers and assigns each pixel to one
(and only one) absorber [13]. This method can identify multiple
chromophores, but the assumption that each pixel only contains
one absorber is not always valid – particularly in the case of blood,
where the spectrum is a linear combination of deoxygenated and
oxygenated hemoglobin, depending on the level of SO2.
An alternative approach, which treats each pixel as a linear
combination of absorbers, provides a more realistic model [20]. Thus,
each pixel can contain multiple absorbers and the relative contribu-
tion of each absorber to the overall spectrum can be estimated. A
linear model is then used to calculate the absorber concentrations in
each pixel while minimzing the mean squared error.C-SA license.
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lengths is critically important. The unique spectral features of each
absorber must be captured by a discrete set of wavelengths.
Ideally, a large number of wavelengths spanning a broad spectrum
should be used. In practice, the number of wavelengths that can be
used is limited by a number of factors, including the linewidth of
the laser, the spectral range of the laser, the spectral-dependent
attenuation of light in tissue, and the pulse repetition rate of the
laser. In PA imaging, the temporal resolution is primarily limited by
the pulse repetition rate of the laser, typically 10–20 Hz for a high
energy tunable laser system. Each imaging wavelength further
decreases the temporal resolution, thereby increasing the overall
imaging time and the likelihood of introducing motion artifacts,
which can be detrimental to spectral unmixing. Thus, wavelength
selection can be used to improve the temporal resolution while
maintaining acceptable levels of uncertainty in the estimated
chromophore concentrations. Heretofore, the optical wavelengths
used in sPA imaging have typically been chosen heuristically. Here
we present a method to select optical wavelengths such that the
concentration estimation remains robust in the presence of noise.
2. Theory
Assuming the stress and thermal conﬁnements are met (i.e., the
laser pulse length is short enough that the local pressure and
temperature rise are constrained to a small volume), the peak
pressure, P, generated by the PA effect depends on the Gru¨neisen
parameter of the tissue, G, the laser ﬂuence at the absorber, F, and
the optical absorption coefﬁcient of the absorber, ma [23]:
P ¼ G Fma (1)
In practice, the pressure detected by an ultrasound transducer
has been attenuated as the pressure wave travels through the
tissue toward the transducer. Accurate reconstruction of P is not
trivial and depends on the geometry and point spread function of
the transducer [24]. In this paper, to simplify the problem and
focus on spectral unmixing, we assume that P has been accurately
reconstructed.
Additional factors also complicate Eq. (1). In practice, F can vary
greatly depending on optical properties of tissue and optical
wavelength, l. Furthermore, ma is a function of l and each of N
distinct absorbers in the region of interest will contribute to the
overall absorption. Thus, Eq. (1) becomes:
PðlÞ ¼ G FðlÞðma1ðlÞ þ ma2 ðlÞ þ    þ maN ðlÞÞ: (2)
The optical absorption can be related to the concentration of an
absorber and the absorption cross section as follows:
mai ðlÞ ¼ C½ieai ðlÞ; (3)
where C[i] is the concentration of the ith absorber and eai ðlÞ is the
molar absorption cross section of the ith absorber at wavelength l.
Eq. (2) is then expanded to:
PðlÞ ¼ G FðlÞðC½1ea1 ðlÞ þ C½2ea2 ðlÞ þ    þ C½NeaN ðlÞÞ: (4)
The Gru¨neisen parameter is tissue-dependent and has little
variation in water-based tissues at constant temperature. There-
fore, it is often assumed to be constant. If the ﬂuence at the
absorber is known, then the optical absorption coefﬁcient vector,
mest(l), can be estimated:
mestðlÞ ¼
PðlÞ
G FðlÞ : (5)
Then Eq. (4) can be simpliﬁed to a set of linear equations:
mest ¼ eC; (6)where mest is a vector whose components correspond to the
reconstructed absorption coefﬁcient at each individual optical
wavelength, e is the absorption cross-section matrix whose rows
correspond to optical wavelengths and columns are the normal-
ized absorption cross section spectra of the optical absorbers (i.e.,
eij ¼ ea j ðliÞÞ, and C is a vector whose elements correspond to the
relative concentration of each optical absorber.
In order to solve Eq. (6) for the absorber concentrations, the
number of optical wavelengths used to acquire images, M, must be
greater than or equal to the number of absorbers, N. In the presence
of noise, it is useful to have M > N, thus making Eq. (6) over-
constrained. In this case, a least squared error estimate of C can be
found:
C  eþmest; (7)
where e+ is the Moore-Penrose pseudoinverse of e, deﬁned as [25]:
eþ ¼ ðeTeÞ1eT: (8)
This estimate of the concentrations has been used to
simultaneously measure SO2 and the concentration of a dye or
nanoparticles in vivo [19,20]. Further modiﬁcations can be made to
Eq. (7) to ensure the sum of the concentrations is 1 and negative
concentrations (an artifact related to ﬁnite signal-to-noise ratio of
the images or the presence of an absorber not included in
absorption cross-section matrix) are avoided [20,26].
3. Materials and methods
3.1. Wavelength selection algorithm
The goal of the wavelength selection algorithm was to select a
set of optical wavelengths in such a way as to increase the accuracy
of existing spectral unmixing algorithms. This set of imaging
wavelengths was chosen from a larger set of wavelengths for
which accurate values of ma(l) for each of the absorbers in the
imaging volume were found from literature or were measured
(e.g., via spectrophotometry). Extraneous wavelengths were
recursively discarded such that the salient features of each
absorber’s spectrum were maintained.
First, the molar absorption matrix, e, was populated with the
absorption spectra with N columns corresponding to individual
absorbers and M rows corresponding to the optical wavelengths.
Only absorbers that are present in the imaging volume and
generate detectable PA signal in the spectral range should be
included in e. The number of rows is limited by a number of factors,
including the spectral range of the laser and spectral resolution of
the absorption spectra data. It was assumed that the rank(e) = N.
That is, the concentrations of all N absorbers can be perfectly
reconstructed from the M wavelengths in the absence of noise.
The smallest singular value of e, smin, was used as an indication
of its stability. As smin! 0, e becomes unstable and may lose rank
in the presence of noise. In other words, the spectrum of one
absorber can be approximated by a linear combination of the other
absorbers. Thus, multiple combinations of absorber concentrations
can represent a single PA spectrum.
Each row was iteratively removed from e and smin was
calculated for the truncated matrix. The row whose removal
resulted in the largest smin was taken to correspond to the least-
critical wavelength and was excluded. This process was recursively
repeated until the desired number of wavelengths was reached. In
practice, the number of wavelengths will depend on the temporal
resolution required, the noise level of the imaging system, and the
desired level of accuracy in concentration estimations. The
implementation of the algorithm is outlined below:
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2. Remove the ﬁrst row of e and calculate smin of the truncated
matrix
3. Repeat step 2 M times for each row of e
4. Let e equal the truncated matrix with the largest smin; let M
equal M  1
5. Repeat steps 2–4 until M is the desired number of wavelengths
or smin reaches the minimum desired level
3.2. Algorithm evaluation
In order to show the robustness of the algorithm, it must be
evaluated on a large number of unique spectra. To achieve this, we
constructed artiﬁcial absorption spectra spanning from 680 nm to
970 nm, a common PA imaging range that is achieved with the
second harmonic of a Nd:YAG laser coupled to an optical
parametric oscillator. The spectra were constructed by creating
ﬁve points consisting of a random wavelength and random
absorption coefﬁcient uniformly distributed between 680–
970 nm and 0–1, respectively. Then, spline interpolation was used
to create a smooth absorption curve across the entire spectral
range. Representative absorption spectra are shown as the solid
lines in Fig. 1a.
Four random spectra were combined into a single optical
absorption matrix. A single spectrum was created from a linear
combination of the four individual spectra. Ten percent additive
white Gaussian noise was added to the spectrum. After pruning
wavelengths using the algorithm described in the previous section,Fig. 1. (a) Representative constructed optical absorption spectra used for algorithm
analysis before (solid lines) and after (dashed lines) 50% wavelength-dependent
attenuation, and (b) a typical attenuation curve with relative changes in laser
ﬂuence ranging from 0% to 100%.a minimum mean squared error estimate of the concentrations
was calculated using the pseudoinverse of the absorption matrix.
The root mean squared (RMS) error, eRMS, of the estimate of each
absorber’s concentration, Cest, was used as a metric for the
performance of the spectral unmixing:
eRMS ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃX
i
ðC½i  Cest½iÞ2
s
: (9)
Thus, an RMS error of 0.1 corresponds to uncertainty in the
estimate equivalent to the added noise. This process was repeated
105 times for different concentrations of absorbers to acquire an
average RMS error, after which the error was correlated to smin.
Next, the process was repeated using either randomly selected
wavelengths or evenly spaced wavelengths and the error was
compared for the three methods as a function of number of
wavelengths.
Finally, we investigated the effect wavelength-dependent
attenuation in tissue models. A decaying exponential (as a function
of optical wavelength) was used to simulate the attenuation of
light in tissue. The attenuation spectrum was scaled to create
relative changes in ﬂuence spanning from 0% to 100% (Fig. 1b). The
relative attenuation can be thought of as a depth-dependent effect.
That is, as the imaging depth increases, the shorter wavelengths
will be preferentially attenuated, and the laser ﬂuence that reaches
a deep-seated absorber will likewise be decreased. The absorption
spectra were scaled by the resulting ﬂuence spectrum to create a
second set of spectra that represent absorbers deep in tissue. The
dashed lines in Fig. 1a show the resulting absorption spectra after a
50% relative attenuation has been applied by multiplying each
absorption spectrum by the relative ﬂuence spectrum. We used the
developed algorithm to select wavelengths for both sets of spectra
and calculated the average spectral distance between each
wavelength selected for the tissue-attenuated spectra and nearest
selected wavelength of original spectra. This provided an estimate
of how tissue attenuation affects the choice of wavelengths. Using
the methods described previously, we estimated eRMS of the
attenuated spectra using the pseudoinverse of the original
absorption matrix decimated to between 4 and 20 wavelengths
using the developed method. Thus, an estimate of the error
induced by ignoring wavelength-dependent attenuation in tissue
was determined.
3.3. Phantom imaging
We performed an imaging experiment of a gelatin phantom to
conﬁrm the results seen in the simulations. We constructed a
phantom containing 8% gelatin (Sigma–Aldrich) and 0.4% of 30 mm
silica particles (U.S. Silica). Six glass pipettes were embedded in the
top surface of the gelatin phantom (Fig. 2a and b). The pipettes
were ﬁlled with 800 mM indocyanine green (ICG) dye (Sigma–
Aldrich), silica-coated gold nanorods (NRs) at a concentration of
approximately 5  1012 particles/mL, or mixtures of the two
solutions containing 20, 40, 60, or 80% NRs. These solutions
correspond to 80, 60, 40, and 20% ICG, respectively. PA images
(Fig. 2c) of the samples were collected using a Vevo LAZR
photoacoustic imaging system (VisualSonics, Inc.) with a LZ-550
linear array transducer (256 elements, 40-MHz center frequency).
Photoacoustic images were acquired across the 680–970 nm
spectral range in steps of 2 nm (for a total of 146 images of each
sample). The PA signal is constrained to the edges of the pipette.
This results from the homogenous distribution of absorbers and
the relatively high center frequency of the transducer [27]. A region
of interest at the top of the sample (white box in Fig. 2d) was used
for further analysis. The PA spectra of the 100% ICG and 100% NR
solutions were used as the reference absorption spectra for
Fig. 2. (a and b) Photographs showing the imaging phantom consisting of pipettes containing ICG dye and silica-coated gold nanorods embedded in a gelatin phantom, (c) a
representative PA image acquired at 880 nm, (d) the same image as in (c) with the location of the pipette (dashed circle) and the region of interest used for further analysis
(white box) indicated, (e) the PA spectra of ICG and silica-coated gold nanorods which were used for spectral unmixing in this experiment, (f) PA images of the region of
interest of each pipette acquired with an excitation wavelength of 880 nm, and (g) the spectrally unmixed sPA images of the same region of interest using PA images from all
146 optical wavelengths. Scale bars are 1 mm.
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(Fig. 2e). The ICG spectrum indicates that it has assumed its
aggregated state [28]. The PA images of the region of interest of
each sample (Fig. 2f) were used to estimate the relative
concentrations of ICG and NRs (Fig. 2g). Following imaging, a 3-
mm optical and ultrasound attenuation layer containing 8%
gelatin, 0.4% silica, and 40 mM ICG was placed above the samples
and imaging was repeated. The ICG served as an optical absorber
and the silica acted as an acoustic and optical scatterer.
4. Results and discussion
The median error in reconstructed concentrations proved to be
inversely proportional to smin across a broad range of wavelengths
and optical spectra (Fig. 3a; R2 = 0.96). For large smin, the spectra
can be unmixed with high accuracy. However, as smin approaches
0, e becomes unstable and the RMS error in the reconstructed
concentrations becomes much greater than the magnitude of the
added noise. Thus, smin provides a good criterion for selecting a
subset of wavelengths for sPA imaging. Furthermore, because the
inverse relationship is linear, smin can be used to predict the level
of precision with which absorber concentrations can be estimated.
Therefore, the imaging wavelengths and contrast agent(s) can be
simultaneously optimized for a given application.
The developed algorithm was compared to two other methods
of wavelength selection: (1) choosing wavelengths randomly and(2) choosing wavelengths that are evenly spaced throughout the
optical range (Fig. 3b). The algorithm consistently yielded better
results than the other two wavelength selection methods. In fact,
only half of the wavelengths are needed to reach the input noise
level than in the case where evenly spaced wavelengths are used.
This improved performance is due to the algorithm’s tendency to
preserve the salient spectral characteristics of the absorbers while
extraneous wavelengths are discarded.
In deriving Eq. (6), we made four important assumptions: (1)
the magnitude of the initial photoacoustic pressure is accurately
reconstructed in each pixel, (2) the Gru¨neisen parameter is
constant throughout the image, (3) the photoacoustic signal
generation is linear, and (4) the ﬂuence has been accurately
estimated in each pixel. Neither the accuracy of the pressure
reconstruction nor the Gru¨neisen parameter depends on the
excitation wavelength. Therefore, errors resulting from the ﬁrst
two assumptions will only affect the magnitude of mest ; the
relative absorber concentration estimates will remain unchanged.
Nonlinear photoacoustic signal generation (e.g., arising from high
laser ﬂuence or aggregated nanoparticles) could lead to a distorted
mest, but these nonlinear effects are not signiﬁcant in most imaging
applications [29–31].
Because the ﬂuence is wavelength-dependent, errors from the
fourth assumption will result in spectral changes of mest.
Estimating the laser ﬂuence that reaches the absorber is a complex
problem and depends on the distribution of all absorbers and
Fig. 3. (a) A scatter plot showing an inverse correlation between smin and the RMS
error in the concentration estimation, and (b) a comparison between three
wavelength selection strategies shows the developed algorithm performs
signiﬁcantly better.
Fig. 4. (a) The average shift in the selected wavelengths after the absorption spectra
have been distorted by wavelength-dependent attenuation, and (b) a scatter plot of
the error in the concentration estimation resulting from these changes in
attenuation in the absence of noise.
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and chromophore concentrations are not separable in general. This
leads to an inverse problem where the chromophore concentra-
tion, absorption coefﬁcient, scattering coefﬁcient, and laser ﬂuence
must be solved for simultaneously [32].
While the four assumptions may introduce small errors into the
estimation of absorber concentrations, they have little effect on the
choice of sPA imaging wavelengths. Fig. 4a shows the average
minimum spectral distance between wavelengths selected before
and after wavelength-dependent optical attenuation. The graph
shows that the algorithm is robust to a broad range of relative
attenuation. Thus, the wavelengths chosen based on the unatten-
uated absorption spectra will typically work well even when the
absorbers are situated deep in tissue. If the wavelength-dependent
attenuation light in tissue is not accounted for (or is incorrectly
estimated), the resulting distortion of the photoacoustic spectrum
will lead to errors in the absorber concentration estimation. Fig. 4b
shows a scatter plot of the errors resulting from spectral-
dependent attenuation of the ﬂuence in the absence of noise. In
general, small errors in the ﬂuence estimation result in smaller
errors in the estimated concentrations. Indeed, errors greater than
20% in the estimated concentration are not common until the
relative attenuation reaches 40%. Although we model the
attenuation spectrum of light as a decaying exponentially as the
optical wavelength increases, we achieved similar results for
arbitrary attenuation spectra. This indicates that, while the
distribution of light in tissue should be modeled for sPA imaging,
small errors in the model will still result in accurate spectral
unmixing results.
One particularly useful application of sPA imaging is the
measurement of blood oxygen saturation. This is often performed
in the absence of an exogenous contrast agent. In this case, only two
spectra need to be considered: deoxygenated and oxygenatedhemoglobin. In the wavelength range of 680 nm to 970 nm we found
that evenly spaced wavelengths performed as well as the developed
algorithm when only these two spectra are considered in the
simulation. We attribute this to the fact that the two spectra are
signiﬁcantly different throughout the wavelength range. Indeed, as
long as wavelengths greater than and less than 800 nm (the
wavelength of equal absorption) are chosen, the oxygen saturation
could be estimated with high accuracy. Our method selected
wavelengths on the edges of the spectral range (i.e., 680 nm and
970 nm) with additional wavelengths contributing to improved
performance mainly through the suppression of uncorrelated noise.
Finally, we applied our wavelength selection algorithm in
imaging of the tissue-mimicking phantom. Fig. 5a shows the
estimated relative NR concentration for the sample containing 40%
NRs (solid line) when wavelengths are selected using the
developed algorithm. It can be seen that sPA imaging provides a
good estimate of the NR concentration even when as few as two
wavelengths are used. When the optical and ultrasonic attenuating
layer was added, the resulting spectrum (Fig. 5a, dashed line)
shows a slight over-estimation of the NRs. This is due to the fact the
3-mm layer preferentially attenuated the shorter wavelengths.
Thus, the ICG peak appeared to be smaller in the acquired PA
signals. This effect could be corrected if we were to model the
transmission of light through the attenuation layer. Fig. 5b shows
the relative NR concentration estimated from the same sample
using evenly spaced wavelengths across the 680–970 nm range.
The concentration estimation is much less stable as wavelengths
are removed, and large errors are observed when fewer than ﬁve
wavelengths are used. When the attenuation layer was added
Fig. 5. (a) The relative concentrations of ICG and silica-coated gold nanorods can be
accurately estimated from PA images acquired at wavelengths selected by the
developed algorithm even when as few as 2 wavelengths are used (solid line).
Adding a 3-mm layer of attenuating gelatin leads to a slight over-estimation of the
nanorods concentration (dashed line). (b) When evenly-spaced wavelengths are
used, the concentration estimate becomes unstable when a small number of
wavelengths are used (solid line), and this effect becomes more pronounced when
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seen as in Fig. 5a. In addition, the concentration estimation errors
are greatly accentuated. Fig. 5c shows a comparison of the
estimated relative NR concentration for each of the samples (in the
absence of the attenuation layer) when using evenly spaced
wavelengths (black lines) and when using wavelengths selected
using the developed algorithm (blue lines). The top and bottom
lines represent controls because the PA spectra acquired from
these samples were used for spectral unmixing. These results
indicate that by carefully selecting imaging wavelengths, signiﬁ-
cant improvements in sPA imaging can be achieved.
The beneﬁts of spectral unmixing and the developed algorithm
depend on several factors. The contrast agent(s) must be selected
to have desirable spectral characteristics. Contrast agents with
distinct spectral features (e.g., a sharp peak or multiple peaks) are
ideal. In general, dyes tend to have a narrower absorption peak
than plasmonic nanoparticles (owing mainly to the polydispersity
which results from commonly-used wet chemistry synthesis
methods). Nanoparticles, however, can exhibit a much higher
optical absorption than dyes [33]. Light penetration in tissue is also
an important factor when choosing contrast agents. Deeper
penetration in tissue at longer wavelengths (near 1064 nm),
results in an increased signal-to-noise ratio [34]. Of course, when
in vivo imaging is performed, there are many more important
characteristics in determining an appropriate contrast agent. These
include toxicity, clearance, circulation time, delivery and molecu-
lar speciﬁcity. Therefore, choosing one of the myriad PA contrast
agents should be deliberate and will depend on the application.
Spectroscopic photoacoustic imaging can be augmented with
other methods to help localize contrast agents and estimate their
concentrations. One method that can be used is collecting a
baseline image before administering the contrast agent. This image
can be subtracted from a second image collected after the contrast
agent has been injected [35]. If it is assumed that the concentration
of endogenous absorbers does not change, then the resulting image
contains only the signal from the contrast agent. After effectively
removing the endogenous absorbers from the image, the sPA
unmixing algorithms can focus on resolving the exogenous
contrast agents. Thus, fewer wavelengths can be used and greater
accuracy in concentration estimation can be achieved. The main
drawback of this method is that it requires two imaging sessions
and, furthermore, exact co-registration between the two images, a
feat that is often difﬁcult to achieve in vivo.
Our method is not limited to sPA imaging. Indeed, it can be
applied to a wide variety of spectroscopic imaging applications to
simultaneously improve accuracy and decrease acquisition time.
For example, the work could be extended to identify light sources
for diffuse optical spectroscopic imaging [36]. It may also be
possible to modify the algorithm to optimize multiplex ﬂuorescent
imaging [37].
5. Conclusion
We have developed an algorithm to choose optical wavelengths
for spectroscopic photoacoustic imaging based on the spectral
characteristics of the absorbers known to be in the region. We have
demonstrated that signiﬁcantly improved results can be achieved
by simply selecting a better set of wavelengths. Furthermore, the
criterion for wavelength selection – smin – provides a useful metric
to predict (and optimize) the ability to spectrally unmix a speciﬁc
set of absorbers. Finally we showed the application of thethe attenuating layer is added (dashed line). (c) The developed algorithm (blue
lines) produces much more reliable estimates of concentration than even spacing
(black lines) in all inclusions. The 0% and 100% lines act as controls since the
absorption spectra were derived from these signals.
G.P. Luke et al. / Photoacoustics 1 (2013) 36–4242algorithm in phantom imaging study. The developed algorithm
performed well for determining the relative concentration of two
contrast agents.
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